## **Core Concept**
Raltegravir is an antiretroviral drug used to treat HIV infection. It belongs to a class of drugs that target a specific step in the HIV replication cycle. Understanding the mechanism of action of antiretroviral drugs is crucial for managing HIV infection.

## **Why the Correct Answer is Right**
Raltegravir works by inhibiting the **integrase enzyme**, which is essential for the integration of HIV DNA into the host cell genome. By blocking this enzyme, raltegravir prevents the HIV virus from replicating. This mechanism is specific to the class of drugs known as **integrase strand transfer inhibitors (INSTIs)**.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because raltegravir does not belong to the class of drugs that inhibit **reverse transcriptase**, which is a different step in the HIV replication cycle targeted by drugs like zidovudine or efavirenz.
- **Option B:** This option is incorrect because raltegravir is not a **protease inhibitor**, which targets the protease enzyme involved in the maturation of the HIV virus. Examples of protease inhibitors include lopinavir and darunavir.
- **Option D:** This option is incorrect because raltegravir does not act as a **CCR5 antagonist**, which blocks the CCR5 receptor on host cells to prevent HIV entry. An example of a CCR5 antagonist is maraviroc.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **raltegravir is specifically indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents**. It's known for its efficacy and relatively favorable side effect profile. Clinicians should be aware of potential drug interactions and resistance patterns when using raltegravir.

## **Correct Answer:** C. Integrase inhibitors.